Publications

1. Yombo JKD, Ghandikota S, Vemulapalli C, Singh P, Jegga AG, Hardie WD, and Madala SK (2024) SEMA3B inhibits TGFβ-induced extracellular matrix protein production and its reduced levels are associated with a decline in lung function in IPF. American Journal of Physiology-Cell Physiology (In Press)
2. Yombo JKD, Ediga HH, Vemulapalli C, Madala SK and Hardie WD (2023) Pulmonary Fibroelastosis - A Review. Matrix Biology 124:1-7 (PMID: 37922998)
3. Santoshi A, Yombo JKD, Reddy GB, Deshpande DA, McCormack FX and Madala SK (2023) Interleukin 31 receptor alpha promotes muscarinic acetylcholine receptor 3-driven calcium signaling and airway hyperresponsiveness in asthma. Nature Communications 14 (1): 8207 (PMID38081868)
4. Gajjala PR, Kasam RK, Soundararajan D, Debora S, Huang SK, Jegga AG and Madala SK (2021) Dysregulated overexpression of Sox9 induces fibroblast activation in pulmonary fibrosis. JCI Insight 6(20):e152503. PMID34520400. Impact factor: 8.515
5. Yombo JKD, Odayar V, Gupta N, Jegga AG, and Madala SK (2021) The protective effects of IL-31RA deficiency during bleomycin-induced pulmonary fibrosis. Frontiers Immunology 12:645717. PMID: 33815402. Impact factor: 7.561
6. Kasam RK, Ghandikota S, Soundarajan, D, Reddy GB, Huang SK, Jegga AG, and Madala SK (2020) Inhibition of Aurora Kinase B attenuates fibroblast activation and pulmonary fibrosis. EMBO Molecular Medicine. 12(9):e12131. PMID:32761869. Impact factor: 10.293
7. Kasam RK, Gajjala PR, Courtney J, Kramer EL, Randell S, Clancy JP, and Madala SK (2020) Fibrocyte accumulation in the lungs of cystic fibrosis patients. J. Cystic Fibrosis 19(5):815-822. PMID: 32593509. Impact factor: 5.482
8. Yombo JKD, Mentink-Kane MM, Wilson MS, Wynn TA, and Madala SK (2019) Heat Shock Protein 70 is a positive regulator of airway inflammation and goblet cell hyperplasia in a mouse model of allergic airway inflammation. Journal of Biological Chemistry 294 (41):
15082-94. PMID: 31431507. Impact factor: 5.157
9. Kasam RK, Reddy GB, Jegga AG, and Madala SK (2019) Dysregulation of mesenchymal cell survival pathways in severe fibrotic lung disease: The effect of nintedanib therapy. Front. Pharmacol. 10:532 PMID: 31156440. Impact factor: 4.400
10. Sontake V, Kasam RK, Debora S, Korfhagen TR, Geereddy BR, White ES, Jegga AG and Madala SK (2018) Wilms' Tumor 1 Drives Fibroproliferation and Myofibroblast Transformation in Severe Fibrotic Lung Disease. JCI insight 3 (16) pii:121252 PMID: 30135315. Impact factor: 8.515
11. Sontake V, Wang Y, Kasam RK, McCormack FK, Debora S, Geereddy BR, Naren AP, White ES, Jegga AG and Madala SK (2017) Hsp90 Regulation of Fibroblast Activation in Pulmonary Fibrosis. JCI Insight 2: e91454. PMID: 28239659. Impact factor: 8.515
12. Sontake V, Kumar SA, Betsy DA, Mario M, Hardie WD, White ES and Madala SK (2015) Fibrocytes Regulate Wilms Tumor 1-Positive Cell Accumulation in Severe Fibrotic Lung Disease. Journal of Immunology 195 (8): 3978-91 PMID: 26371248. Impact factor: 5.422